AU2156501A - Method for the detection of mammalian carcinomas - Google Patents

Method for the detection of mammalian carcinomas Download PDF

Info

Publication number
AU2156501A
AU2156501A AU21565/01A AU2156501A AU2156501A AU 2156501 A AU2156501 A AU 2156501A AU 21565/01 A AU21565/01 A AU 21565/01A AU 2156501 A AU2156501 A AU 2156501A AU 2156501 A AU2156501 A AU 2156501A
Authority
AU
Australia
Prior art keywords
cancer
sample
spatial distribution
cell
specific component
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU21565/01A
Other languages
English (en)
Inventor
Roeland Van Driel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universiteit Van Amsterdam
Original Assignee
Universiteit Van Amsterdam
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universiteit Van Amsterdam filed Critical Universiteit Van Amsterdam
Publication of AU2156501A publication Critical patent/AU2156501A/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU21565/01A 1999-11-01 2000-11-01 Method for the detection of mammalian carcinomas Abandoned AU2156501A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP99203582 1999-11-01
EP99203582 1999-11-01
PCT/EP2000/011050 WO2001033229A1 (en) 1999-11-01 2000-11-01 Method for the detection of mammalian carcinomas

Publications (1)

Publication Number Publication Date
AU2156501A true AU2156501A (en) 2001-05-14

Family

ID=8240801

Family Applications (1)

Application Number Title Priority Date Filing Date
AU21565/01A Abandoned AU2156501A (en) 1999-11-01 2000-11-01 Method for the detection of mammalian carcinomas

Country Status (8)

Country Link
EP (1) EP1226439A1 (ja)
JP (1) JP2003513282A (ja)
AU (1) AU2156501A (ja)
CA (1) CA2389364A1 (ja)
HU (1) HUP0203269A2 (ja)
NZ (1) NZ519065A (ja)
WO (1) WO2001033229A1 (ja)
ZA (1) ZA200203401B (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5339676B2 (ja) * 2003-02-21 2013-11-13 メドベット サイエンス ピーティーワイ． リミテッド 細胞を検出する方法、およびこれに有用な薬剤
US20090029408A1 (en) * 2007-07-25 2009-01-29 Wyeth Methods for Characterizing Cell Proximity
EP2467499A1 (en) * 2009-08-21 2012-06-27 Oncotherapy Science, Inc. Cstf2 for target genes of lung cancer therapy and diagnosis
US11551360B2 (en) 2020-04-28 2023-01-10 QATAR UNIVERSITY, Office of Academic Research Device and method for cancer detection

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5264343A (en) * 1990-08-31 1993-11-23 Eleanor Roosevelt Institute Method for distinguishing normal and cancer cells
US5599919A (en) * 1994-12-09 1997-02-04 Fox Chase Cancer Center Nucleic acid encoding a transiently-expressed kinetochore protein, and methods of use
US5891857A (en) * 1996-02-20 1999-04-06 Vanderbilt University Characterized BRCA1 and BRCA2 proteins and screening and therapeutic methods based on characterized BRCA1 and BRCA2 proteins

Also Published As

Publication number Publication date
NZ519065A (en) 2004-03-26
ZA200203401B (en) 2003-04-29
EP1226439A1 (en) 2002-07-31
CA2389364A1 (en) 2001-05-10
JP2003513282A (ja) 2003-04-08
HUP0203269A2 (en) 2003-02-28
WO2001033229A1 (en) 2001-05-10

Similar Documents

Publication Publication Date Title
AU2010241288B2 (en) Method and quantification assay for determining c-kit/SCF/pAKT status
Rhodes et al. A formalin-fixed, paraffin-processed cell line standard for quality control of immunohistochemical assay of HER-2/neu expression in breast cancer
Onsum et al. Single-cell quantitative HER2 measurement identifies heterogeneity and distinct subgroups within traditionally defined HER2-positive patients
DE60200248T2 (de) Verfahren für Lösung-basierte Diagnose
DE69929185T2 (de) Tumormarker
US20100075341A1 (en) Standardized evaluation of therapeutic efficacy based on cellular biomarkers
CA2623445A1 (en) Comprehensive diagnostic testing procedures for personalized anticancer chemotherapy (pac)
CN103392009B (zh) 前列腺活组织检查中低级pin(lg‑pin)中erg基因重排和蛋白质过表达的存在
KR20030080002A (ko) 순환 암 세포를 신속하고 효과적으로 분리하기 위한 방법및 시약
Pauwels et al. Clear cell sarcoma of the stomach
AU2156501A (en) Method for the detection of mammalian carcinomas
Petterino et al. Immunohistochemical evaluation of STAT3-p-tyr705 expression in feline mammary gland tumours and correlation with histologic grade
Watson et al. Flow cytometric quantitation of the c-myc oncoprotein in archival neoplastic biopsies of the colon
Cho et al. CDX-2 protein and mRNA expression in canine intestinal adenocarcinoma
WO2024204325A1 (ja) 細胞膜タンパク質を検出する方法
Yigzaw et al. Review of Immunohistochemistry Techniques: Applications, Current Status, and Future Perspectives
Pala et al. Problems In Determining Her2 Status In Breast Carcinoma
Fischer et al. Method for procuring specific populations of viable human prostate cells for research
Rosolem et al. Paulo Henrique Leal Bertolo et al.(2019) Relationship Between the Immunodetection of Alpha-Smooth Muscle Actin and the Aggressiveness of Mammary Papillar Tumors in Female Dog
AU2002313797A1 (en) Method and quantification assay for determining c-kit/SCF/pAKT status

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase
TH Corrigenda

Free format text: IN VOL 15, NO 34, PAGE(S) 7254-7258 UNDER THE HEADING APPLICATIONS LAPSED, REFUSED OR WITHDRAWN PLEASE DELETE ALL REFERENCE TO APPLICATION NO. 75498/00, 77764/00, 77843/00, 10202/01, 10344/01, 10348/01, 10394/01, 10443/01, 10446/01, 10511/01, 11543/01, 11551/01, 12831/01, 12838/01, 12847/01, 12862/01, 13880/01, 15598/01 AND 21565/01